Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Japan Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20043
20051
20065
20074
20081
20093
201011
20118
20128
20135
20145
20152
20166
20174
20182
20191
20202
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Terminated4
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S36
Astellas Pharma Inc9
Takeda9
Eli Lilly and Company6
AstraZeneca4
Sanofi4
GlaxoSmithKline3
Kobe University2
Kyowa Kirin Co., Ltd.2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus81
Diabetes Mellitus, Type 254
Diabetes Mellitus, Type 110
Glucose Metabolism Disorders5
Metabolic Diseases4
Endocrine System Diseases3
Obesity3
Coronary Artery Disease2
Diabetes Mellitus, Lipoatrophic2
Insulin Resistance2

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.